4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-26-000205
CHIEF EXECUTIVE OFFICER gave up 46,777 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2026-01-09 | Shares withheld for taxes | −46,777 | $5.35 | $250,257 | 6,640,023 | D |
Loading xslF345X05/ownership.xml…